Hydroxyzine Pamoate recalls
Hydroxyzine Pamoate products have been recalled 3 times, most recently on 15 Jun 2022. The recalling company is usually Teva Pharmaceuticals U. The most common reason is manufacturing (cgmp) deviations.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why hydroxyzine pamoate is recalled
Companies
Product types
By year
All hydroxyzine pamoate recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | HydrOXYzine Pamoate Capsules, USP, 50 mg recalledHydroxyzine Pamoate | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Teva Hydroxyzine Pamoate Capsules, USP, 25 mg recalledHydroxyzine Pamoate | Teva Pharmaceuticals U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Teva Hydroxyzine Pamoate Capsules, USP, 100 mg recalledHydroxyzine Pamoate | Teva Pharmaceuticals U | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.